The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APP<sub>swe</sub> Cell Model of AD.

Front Pharmacol · 2018 · PMC5893754 · PMID 29670521

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The ratio of Aβ 1-42 to Aβ 1-40 in N2a/APP cell lysates showed a trend of modest increase compared to that in N2a/WT cell lysates ( Figure 2C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.